Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
CG Oncology, Inc.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
TILT Biotherapeutics Ltd.
Lokon Pharma AB
Institut Pasteur du Cambodge
Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
TILT Biotherapeutics Ltd.
Stanford University
Baylor College of Medicine
Baylor College of Medicine
Columbia University
University Hospital Freiburg
University of Pittsburgh
Pediatric Transplantation & Cellular Therapy Consortium
GeoVax, Inc.
University of Oxford
Columbia University
Beijing Neurosurgical Institute
EpicentRx, Inc.
Henry Ford Health System
AlloVir
AlloVir
Orca Therapeutics B.V.
Duke University
Northwestern University
University of Birmingham
Medical College of Wisconsin
AlloVir
CG Oncology, Inc.
Seoul National University Bundang Hospital
Biogen
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shenzhen Geno-Immune Medical Institute
Seoul National University Hospital
Henry Ford Health System
AlloVir
Syneos Health
National Institutes of Health Clinical Center (CC)
Panacela Labs LLC
Panacela Labs LLC
Institut Català d'Oncologia
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Biotech Equity Partners Pty Ltd
Cell Genesys